diabetes drugs

diabetes drugs

featured image of €50 Million Boost for GLP-1 Production in France!
Companies

€50 Million Boost for GLP-1 Production in France!

BIOT

🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀

featured image of Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
Companies

Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market

BIOT

📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact